(BHF) Brighthouse Financial - Ratings and Ratios
Annuities, Life Insurance
BHF EPS (Earnings per Share)
BHF Revenue
Description: BHF Brighthouse Financial
Brighthouse Financial, Inc. is a leading provider of annuity and life insurance products in the United States, operating through three main segments: Annuities, Life, and Run-off. The companys product portfolio is designed to meet the needs of contract holders and policyholders for protected wealth accumulation, wealth transfer, and income security.
From a strategic perspective, Brighthouse Financials business model is centered around providing financial security and protected wealth transfer to its customers. The Annuities segment offers a range of products, including variable, fixed, index-linked, and income annuities, which are designed to help customers accumulate wealth on a tax-deferred basis. The Life segment provides a range of life insurance products, including term, universal, whole, and variable life insurance, which are designed to provide financial security and protected wealth transfer to policyholders.
In terms of key performance indicators (KPIs), Brighthouse Financials return on equity (RoE) of 12.34% indicates a relatively strong profitability profile. However, the companys price-to-earnings (P/E) ratio of 6.12 and forward P/E ratio of 2.51 suggest that the stock may be undervalued relative to its earnings potential. Additionally, the companys market capitalization of $2.7 billion indicates a relatively small-cap stock with potential for growth.
To further evaluate Brighthouse Financials performance, other relevant KPIs could include the companys asset under management (AUM), net interest margin (NIM), and capital adequacy ratios. AUM would provide insight into the companys scale and ability to generate revenue, while NIM would indicate the companys ability to generate income from its investment portfolio. Capital adequacy ratios, such as the risk-based capital (RBC) ratio, would provide insight into the companys solvency and ability to meet its long-term obligations.
Additional Sources for BHF Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
BHF Stock Overview
Market Cap in USD | 2,747m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 2017-07-17 |
BHF Stock Ratings
Growth Rating | 45.5 |
Fundamental | 3.13 |
Dividend Rating | 0.0 |
Rel. Strength | -21.9 |
Analysts | 3 of 5 |
Fair Price Momentum | 39.32 USD |
Fair Price DCF | 140.87 USD |
BHF Dividends
Currently no dividends paidBHF Growth Ratios
Growth Correlation 3m | -84.8% |
Growth Correlation 12m | 65.6% |
Growth Correlation 5y | 45% |
CAGR 5y | 9.96% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 0.55 |
Alpha | -21.45 |
Beta | 1.007 |
Volatility | 41.10% |
Current Volume | 998.9k |
Average Volume 20d | 777.4k |
Stop Loss | 44.2 (-4.3%) |
As of August 03, 2025, the stock is trading at USD 46.18 with a total of 998,869 shares traded.
Over the past week, the price has changed by -8.03%, over one month by -14.13%, over three months by -20.79% and over the past year by -5.45%.
Neither. Based on ValueRay´s Fundamental Analyses, Brighthouse Financial is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.13 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BHF is around 39.32 USD . This means that BHF is currently overvalued and has a potential downside of -14.85%.
Brighthouse Financial has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold BHF.
- Strong Buy: 1
- Buy: 1
- Hold: 5
- Sell: 1
- Strong Sell: 1
According to our own proprietary Forecast Model, BHF Brighthouse Financial will be worth about 43.5 in August 2026. The stock is currently trading at 46.18. This means that the stock has a potential downside of -5.89%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 59.4 | 28.7% |
Analysts Target Price | 60.4 | 30.7% |
ValueRay Target Price | 43.5 | -5.9% |